1.29
전일 마감가:
$1.28
열려 있는:
$1.3
하루 거래량:
531.32K
Relative Volume:
0.50
시가총액:
$174.33M
수익:
$108.81M
순이익/손실:
$-186.70M
주가수익비율:
-1.5321
EPS:
-0.842
순현금흐름:
$-16.83M
1주 성능:
-15.69%
1개월 성능:
-23.67%
6개월 성능:
-19.38%
1년 성능:
-4.44%
Organigram Global Inc Stock (OGI) Company Profile
명칭
Organigram Global Inc
전화
-
주소
-
Compare OGI vs TAK, ZTS, HLN, TEVA, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
OGI
Organigram Global Inc
|
1.29 | 172.97M | 108.81M | -186.70M | -16.83M | -0.842 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.46 | 58.03B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
126.65 | 55.37B | 9.40B | 2.65B | 2.24B | 5.935 |
|
HLN
Haleon Plc Adr
|
11.20 | 49.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.98 | 39.50B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
473.66 | 20.50B | 3.13B | 1.27B | 1.12B | 26.39 |
Organigram Global Inc Stock (OGI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-27 | 개시 | Canaccord Genuity | Buy |
| 2024-07-17 | 재개 | Canaccord Genuity | Speculative Buy |
| 2024-04-15 | 업그레이드 | Alliance Global Partners | Neutral → Buy |
| 2023-01-13 | 업그레이드 | Stifel | Hold → Buy |
| 2022-01-12 | 업그레이드 | Canaccord Genuity | Hold → Speculative Buy |
| 2021-05-11 | 업그레이드 | CIBC | Sector Underperform → Neutral |
| 2021-04-14 | 다운그레이드 | CIBC | Neutral → Sector Underperform |
| 2021-04-08 | 업그레이드 | BMO Capital Markets | Underperform → Market Perform |
| 2021-03-10 | 다운그레이드 | BMO Capital Markets | Market Perform → Underperform |
| 2021-01-13 | 다운그레이드 | Alliance Global Partners | Buy → Neutral |
| 2021-01-13 | 다운그레이드 | Canaccord Genuity | Speculative Buy → Hold |
| 2020-07-07 | 개시 | Alliance Global Partners | Buy |
| 2020-01-15 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-01-13 | 개시 | BofA/Merrill | Underperform |
| 2020-01-09 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2019-11-12 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2019-11-05 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-10-11 | 업그레이드 | Jefferies | Hold → Buy |
모두보기
Organigram Global Inc 주식(OGI)의 최신 뉴스
Organigram Global (TSX:OGI) Valuation Check After Swing To Quarterly Net Profit - simplywall.st
StockTalk | Cannabis Report: I’m HIGHLY into you | 2026-02-13 | Investing News - Stockhouse
Organigram. Buy, Sell or Hold? - Cantech Letter
Atb Cormark Cm Downgrades Organigram Global (NASDAQ:OGI) to Moderate Buy - MarketBeat
Organigram Global Inc. (NASDAQ: OGI) Q1 2026 earnings call transcript - MSN
Organigram Global Inc. (TSE:OGI) Stocks Pounded By 26% But Not Lagging Industry On Growth Or Pricing - simplywall.st
Is Organigram Global Inc. stock a safe haven assetCEO Change & Real-Time Buy Signal Alerts - mfd.ru
Organigram Global Is Now A Strong Buy (NASDAQ:OGI) - Seeking Alpha
Promising Cannabis Stocks To ConsiderFebruary 11th - MarketBeat
Organigram Global Inc. (NASDAQ:OGI) Q1 2026 Earnings Call Transcript - Insider Monkey
Organigram Global (OGI) Reports Strong Q1 Revenue Growth - GuruFocus
OrganiGram: Fiscal Q1 Earnings Snapshot - theheraldreview.com
Organigram Global Q1 Earnings Call Highlights - MarketBeat
Organigram Global Inc (OGI) Q1 2026 Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada
Promising Cannabis Stocks To Watch TodayFebruary 10th - MarketBeat
Organigram Global Q1 2026 Earnings Call Transcript - MarketBeat
Organigram Global Inc (OGI) Q1 2026 Earnings Call Highlights: Re - GuruFocus
Q1 FY2026: Organigram sees significant annual growth in Canadian, international sales - StratCann
Organigram Global (NASDAQ:OGI) Announces Quarterly Earnings Results - MarketBeat
Earnings call transcript: OrganiGram Q1 2026 sees strong revenue growth By Investing.com - Investing.com Nigeria
Earnings call transcript: OrganiGram Q1 2026 sees strong revenue growth - Investing.com
Organigram reports revenue boost in Q1 | 2026-02-10 | Investing News - Stockhouse
OrganiGram (OGI) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
Organigram Global Q1 Earnings Report: What Investors Need to Know - Benzinga
Organigram (OGI) Reports Strong Q1 Growth and Expanding Internat - GuruFocus
Organigram Swings to Q1 Profit - 富途牛牛
Organigram Delivers Strong Q1 2026 Growth and Expands U.S. Reach - TipRanks
Organigram Brief: Q1 Net income was $20.0 Million Vs Net Loss of $27.5 Million in Q1 Fiscal 2025 - marketscreener.com
Organigram Reports First Quarter Fiscal 2026 Results - The Joplin Globe
Press Release: Organigram Reports First Quarter Fiscal 2026 Results - 富途牛牛
OrganiGram Global Inc. Q1 Adjusted EBITDA jumps to CAD 5.3 million, up 2.7 times year-over-year - Longbridge
Organigram global Q1 2026 earnings preview - MSN
Earnings Preview For OrganiGram Holdings - Benzinga
Best Cannabis Stocks To ResearchFebruary 9th - MarketBeat
Organigram Global (OGI) Set to Announce Q1 Earnings - GuruFocus
Organigram Sets February 10 Date to Release Q1 2026 Results - The Globe and Mail
Top Cannabis Stocks To ResearchFebruary 3rd - MarketBeat
Organigram Global Inc. (OGI) sets Feb. 10 call for Q1 2026 results - Stock Titan
Organigram to Report First Quarter Fiscal 2026 Results on February 10, 2026 - Bluefield Daily Telegraph
Organigram Global (OGI) Expected to Announce Earnings on Tuesday - MarketBeat
Investor Mood: What is Organigram Global Incs valuation compared to sectorJuly 2025 Snapshot & Fast Gain Stock Trading Tips - baoquankhu1.vn
Organigram Global scales US presence, expands hemp-derived THC beverage portfolio - MSN
Best Cannabis Stocks To Follow TodayJanuary 31st - MarketBeat
Organigram Global (NASDAQ:OGI) Lowered to "Sell" Rating by Wall Street Zen - MarketBeat
Cannabis Stocks To ResearchJanuary 2nd - MarketBeat
OrganiGram Sets March 30, 2026 Date for Annual and Special Shareholder Meeting - TipRanks
Organigram Global Inc. (OGI:CA) Canaccord Genuity Forecasts 35% Upside - The Globe and Mail
Organigram Global (NASDAQ:OGI) Now Covered by Canaccord Genuity Group - MarketBeat
Promising Cannabis Stocks To Add to Your WatchlistJanuary 3rd - MarketBeat
Organigram Global Inc (OGI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):